Journal
SCIENCE
Volume 291, Issue 5509, Pages 1790-1792Publisher
AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.1058092
Keywords
-
Categories
Funding
- NCI NIH HHS [CA 66736] Funding Source: Medline
- NIGMS NIH HHS [GM 22172] Funding Source: Medline
Ask authors/readers for more resources
The macrocyclic core of the antibiotic erythromycin, 6-deoxyerythronolide B (6dEB), is a complex natural product synthesized by the soil bacterium Saccharopolyspora erythraea through the action of a multifunctional polyketide synthase (PKS). The engineering potential of modular PKSs is hampered by the Limited capabilities for molecular biological manipulation of organisms (principally actinomycetes) in which complex polyketides have thus far been produced. To address this problem, a derivative of Escherichia coli has been genetically engineered. The resulting cellular catalyst converts exogenous propionate into 6dEB with a specific productivity that compares well with a high-producing mutant of S. erythraea that has been incrementally enhanced over decades for the industrial production of erythromycin.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available